Cargando…
Study of the pharmacokinetic changes of Tramadol in diabetic rats
BACKGROUND: Besides the pathological states, diabetes mellitus may also alter the hepatic biotransformation of pharmaceutical agents. It is advantageous to understand the effect of diabetes on the pharmacokinetic of drugs. The objective of this study was to define the pharmacokinetic changes of tram...
Autores principales: | Lavasani, Hoda, Sheikholeslami, Behjat, Ardakani, Yalda H, Abdollahi, Mohammad, Hakemi, Lida, Rouini, Mohammad-Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3610115/ https://www.ncbi.nlm.nih.gov/pubmed/23497674 http://dx.doi.org/10.1186/2008-2231-21-17 |
Ejemplares similares
-
Investigation of MDMA Inhibitory Effect on CytochromeP450 3A4 in Isolated Perfused Rat Liver Model Using Tramadol
por: Sheikholeslami, Behjat, et al.
Publicado: (2021) -
Gender Dependency in Streoselective Pharmacokinetics of Tramadol and Its Phase I Metabolites in Relation to CYP2D6 Phenotype in Iranian Population
por: Hosseinzadeh Ardakani, Yalda, et al.
Publicado: (2018) -
Pharmacokinetics of mirtazapine and its main metabolites after single intravenous and oral administrations in rats at two dose rates
por: Rouini, Mohammad-Reza, et al.
Publicado: (2014) -
Evaluation of changes in cytochrome P450 2C19 activity in type 2 diabetic rats before and after treatment, by using isolated perfused liver model
por: Neyshaburinezhad, Navid, et al.
Publicado: (2020) -
A Rapid and Sensitive HPLC-Fluorescence Method for Determination of Mirtazapine and Its two Major Metabolites in Human Plasma
por: Lavasani, Hoda, et al.
Publicado: (2014)